These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 35646734

  • 21. Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa.
    Yin D, Wu S, Yang Y, Shi Q, Dong D, Zhu D, Hu F, China Antimicrobial Surveillance Network (CHINET) Study Group.
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30617091
    [Abstract] [Full Text] [Related]

  • 22. In Vitro Analysis of Activities of 16 Antimicrobial Agents against Gram-Negative Bacteria from Six Teaching Hospitals in China.
    Chen H, Wang Z, Li H, Wang Q, Zhao C, He W, Wang X, Zhang F, Wang H.
    Jpn J Infect Dis; 2015 Apr; 68(4):263-7. PubMed ID: 25672407
    [Abstract] [Full Text] [Related]

  • 23. Susceptibility profile of bla OXA-23 and metallo-β-lactamases co-harbouring isolates of carbapenem resistant Acinetobacter baumannii (CRAB) against standard drugs and combinations.
    Sharma S, Banerjee T, Yadav G, Kumar A.
    Front Cell Infect Microbiol; 2022 Apr; 12():1068840. PubMed ID: 36683677
    [Abstract] [Full Text] [Related]

  • 24. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
    [Abstract] [Full Text] [Related]

  • 25. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 26. In Vitro Activity of Cefiderocol against U.S. and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance Program.
    Shortridge D, Streit JM, Mendes R, Castanheira M.
    Microbiol Spectr; 2022 Apr 27; 10(2):e0271221. PubMed ID: 35262394
    [Abstract] [Full Text] [Related]

  • 27. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
    Piérard D, Stone GG.
    BMC Infect Dis; 2021 Jun 23; 21(1):600. PubMed ID: 34162341
    [Abstract] [Full Text] [Related]

  • 28. [Evaluation of In vitro Efficacy of Meropenem/Colistin and Meropenem/Fosfomycin Combinations on Multidrug Resistant Gram-Negative Bacilli].
    Adaleti R, Nakipoğlu Y, Arıcı N, Kansak N, Çalık Ş, Şenbayrak S, Balık R, Aksaray S.
    Mikrobiyol Bul; 2023 Jul 23; 57(3):365-377. PubMed ID: 37462301
    [Abstract] [Full Text] [Related]

  • 29. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2002 Feb 23; 55(1):22-60. PubMed ID: 11977920
    [Abstract] [Full Text] [Related]

  • 30. Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa.
    Delgado-Valverde M, Portillo-Calderón I, Alcalde-Rico M, Conejo MC, Hidalgo C, Del Toro Esperón C, Pascual Á.
    Eur J Clin Microbiol Infect Dis; 2024 Mar 23; 43(3):445-457. PubMed ID: 38157139
    [Abstract] [Full Text] [Related]

  • 31. Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012.
    Sader HS, Castanheira M, Flamm RK, Farrell DJ, Jones RN.
    Antimicrob Agents Chemother; 2014 Mar 23; 58(3):1684-92. PubMed ID: 24379201
    [Abstract] [Full Text] [Related]

  • 32. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W, Tantichattanon W, Wongwatcharapaiboon S, Treeratweeraphong V.
    J Med Assoc Thai; 2008 Oct 23; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019.
    Karlowsky JA, Hackel MA, Takemura M, Yamano Y, Echols R, Sahm DF.
    Antimicrob Agents Chemother; 2022 Feb 15; 66(2):e0199021. PubMed ID: 34807757
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients.
    Díez-Aguilar M, Ekkelenkamp M, Morosini MI, Merino I, de Dios Caballero J, Jones M, van Westreenen M, Tunney MM, Cantón R, Fluit AC.
    Int J Antimicrob Agents; 2019 Jan 15; 53(1):84-88. PubMed ID: 30240837
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In vitro activity of cefiderocol against comparators (ceftazidime-avibactam, ceftazidime-avibactam/ aztreonam combination, and colistin) against clinical isolates of meropenem-resistant Klebsiella pneumoniae from India.
    Borde K, Kareem MA, Sharma RM, Dass SM, Ravi V, Mathai D.
    Microbiol Spectr; 2023 Sep 22; 11(5):e0084723. PubMed ID: 37737637
    [Abstract] [Full Text] [Related]

  • 40. In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from U.S. Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes.
    Castanheira M, Davis AP, Mendes RE, Serio AW, Krause KM, Flamm RK.
    Antimicrob Agents Chemother; 2018 Aug 22; 62(8):. PubMed ID: 29866862
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.